Methylation of intestinal and hepatic DNA in rats treated with methylazoxymethanol acetate

Cancer
|November 1, 1977
PubMed

Insights

Methylazoxymethanol acetate causes cancer in rat intestines and liver. Despite liver DNA showing high 7-methylguanine, the descending colon, a sensitive site, had minimal 7-methylguanine, suggesting no correlation with tumor induction.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Molecular Biology

Background:

  • The descending colon is highly sensitive to methylazoxymethanol acetate's carcinogenic effects, comparable to the liver.
  • Understanding the relationship between DNA methylation and tumor induction is crucial for carcinogen research.

Purpose of the Study:

  • To investigate the correlation between DNA methylation levels and tumor induction by methylazoxoxymethanol acetate in rat tissues.
  • To quantify 7-methylguanine levels in DNA from the duodenum, descending colon, and liver of rats exposed to the carcinogen.

Main Methods:

  • Rats were treated with methylazoxymethanol acetate.
  • High-pressure liquid chromatography was used to detect and quantify methylated purines in DNA.
  • DNA was isolated from the duodenum, descending colon, and liver for analysis.

Main Results:

  • Significant levels of 7-methylguanine were detected in DNA isolated from the liver of treated rats.
  • Minimal amounts of 7-methylguanine were found in DNA from the descending colon of treated rats.
  • No correlation was observed between 7-methylguanine levels and tumor sensitivity in the descending colon.

Conclusions:

  • The level of 7-methylguanine in DNA does not correlate with the sensitivity of the descending colon to methylazoxymethanol acetate-induced tumor formation.
  • These findings suggest that DNA methylation at the 7-methylguanine site is not the primary mechanism driving carcinogenicity in this model.